Publications by authors named "Ming Yang Xushi"
Article Synopsis
- Multidrug resistance in cancer treatment, caused by the overexpression of P-glycoprotein, severely limits the effectiveness of chemotherapy.
- The study highlights O-(4-ethoxyl-butyl)-berbamine (EBB) as a promising agent that enhances the effectiveness of doxorubicin against drug-resistant cancer cells by blocking P-glycoprotein's function and reducing its expression.
- Co-treating cancer cells with EBB and doxorubicin leads to significant cell cycle arrest and increased cell death, indicating a strong potential for improving cancer chemotherapy outcomes.
